XML 18 R33.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2014
Business Acquisition [Line Items]  
Cangene pro forma
The following pro forma information is presented as if the acquisition had occurred on January 1, 2013, and combines the historical results of operations of the Company and Cangene for the year ended December 31, 2014 and 2013.

  
December 31,
 
(in thousands)
 
2014
  
2013
 
Pro forma revenue
 
$
462,446
  
$
428,194
 
Pro forma net income
 
$
34,624
  
$
10,994
 

Cangene Corporation [Member]  
Business Acquisition [Line Items]  
Purchase Price Allocation

The table below summarizes the allocation of the purchase price based upon estimated fair values of assets acquired and liabilities assumed at February 21, 2014.

(in thousands)
  
 
  
Fair value of tangible assets acquired and liabilities assumed:
  
Cash
 
$
43,631
 
Accounts receivable
  
19,652
 
Inventory (i)
  
55,259
 
Prepaid expenses and other assets
  
2,375
 
Property, plant and equipment
  
40,264
 
Deferred taxes, net
  
21,337
 
Income tax receivable
  
2,452
 
Accounts payable and accrued liabilities
  
(22,918
)
Provision for chargebacks
  
(1,946
)
Contingent purchase consideration
  
(1,284
)
Deferred revenue
  
(6,378
)
Total fair value of tangible assets acquired and liabilities assumed
  
152,444
 
 
    
Acquired in-process research and development
  
8,300
 
Acquired intangible assets
  
36,200
 
Goodwill
  
24,566
 
Total purchase price
 
$
221,510
 

(i) Acquired inventory reflects a $8.8 million adjustment to record inventory at fair value, referred to as a step-up adjustment. The $8.8 million step-up is estimated to be amortized through cost of product sales and contract manufacturing over the next five years based on expected inventory turnover, which will increase cost of product sales and contract manufacturing during such period.

Fair Value of Intangible Assets

The table below summarizes the preliminary estimated fair value of intangible assets acquired and the estimated amortization periods:

 
 
Amortization
 
 
 
Period
 
( in thousands)
Amount
 
in years
 
 
  
Corporate Trade Name
 
$
2,800
   
5.0
 
Marketed Products
  
8,100
   
10.0
 
Licensed Products
  
3,100
   
7.0
 
Biodefense Products
  
16,700
   
12.0
 
Contract Manufacturing
  
5,500
   
8.0
 
 
        
Total identified intangible assets
 
$
36,200
     

EV 035 [Member]  
Business Acquisition [Line Items]  
Purchase Price Allocation
The table below summarizes the preliminary allocation of the purchase price based upon fair values of assets acquired. As of the date of this filing, the valuation of acquired intangible assets and other fair value adjustments are not complete as the Company is obtaining and analyzing additional information related to the aforementioned items.  As such, the purchase price allocation is subject to change.

(in thousands)
 
 
Acquired intangible assets
 
$
27,700
 
Goodwill
  
2,000
 
Total purchase price
 
$
29,700
 

Preliminary Purchase Price
The total preliminary purchase price is summarized below:

(in thousands)
 
 
Amount of cash paid to Evolva Holdings SA
 
$
1,500
 
Fair value of contingent consideration
  
28,200
 
Total purchase price
 
$
29,700
 

HPPD [Member]  
Business Acquisition [Line Items]  
Purchase Price Allocation
The table below summarizes the allocation of the purchase price based upon fair values of assets acquired and liabilities assumed at August 1, 2013. 

(in thousands)
 
 
Acquired intangible assets
  
32,099
 
Goodwill
  
9,916
 
Acquired equipment
  
1,543
 
Other
  
11
 
Assumed liabilities
  
(1,464
)
Total purchase price
 
$
42,105
 


Preliminary Purchase Price
The total purchase price is summarized below:

(in thousands)
 
 
Amount of cash paid to Bracco Diagnostics Inc.
 
$
25,873
 
Fair value of contingent purchase consideration
  
16,232
 
Total purchase price
 
$
42,105